《內房》龍光(03380.HK):逾八成境外債權人加入經修訂債權人支持協議
龍光集團(03380.HK)早前宣布與債權人小組就整體債權人支持協議(整體CSA)達成修訂協議,集團公布,截至昨日(24日)下午5時,持有公司境外債務本金總額(包括現有票據、股本掛鉤證券、現有貸款、結構性融資及擔保債務,以及額外境外債務)的超過80%同意債權人已加入經修訂整體CSA,衷心感謝債權人的支持。
因應經修訂整體重組方案進展順利,早鳥CSA費用已於昨日截止,龍光表示未來將加快推進境外債務整體重組方案實施落地,保護債權人整體利益,並呼籲尚未加入經修訂整體CSA的境外債權人盡快加入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.